<VariationArchive RecordType="classified" VariationID="29973" VariationName="NM_000276.4(OCRL):c.167_168del (p.Ile56fs)" VariationType="Deletion" Accession="VCV000029973" Version="4" NumberOfSubmissions="1" NumberOfSubmitters="1" DateLastUpdated="2023-12-25" DateCreated="2021-06-26" MostRecentSubmission="2021-06-26">
  <RecordStatus>current</RecordStatus>
  <Species>Homo sapiens</Species>
  <ClassifiedRecord>
    <SimpleAllele AlleleID="38928" VariationID="29973">
      <GeneList>
        <Gene Symbol="OCRL" FullName="OCRL inositol polyphosphate-5-phosphatase" GeneID="4952" HGNC_ID="HGNC:8108" Source="submitted" RelationshipType="within single gene">
          <Location>
            <CytogeneticLocation>Xq26.1</CytogeneticLocation>
            <SequenceLocation Assembly="GRCh38" AssemblyAccessionVersion="GCF_000001405.38" AssemblyStatus="current" Chr="X" Accession="NC_000023.11" start="129540259" stop="129592556" display_start="129540259" display_stop="129592556" Strand="+" />
            <SequenceLocation Assembly="GRCh37" AssemblyAccessionVersion="GCF_000001405.25" AssemblyStatus="previous" Chr="X" Accession="NC_000023.10" start="128674251" stop="128726532" display_start="128674251" display_stop="128726532" Strand="+" />
          </Location>
          <OMIM>300535</OMIM>
          <Haploinsufficiency last_evaluated="2021-01-12" ClinGen="https://www.ncbi.nlm.nih.gov/projects/dbvar/ISCA/isca_gene.cgi?sym=OCRL">Sufficient evidence for dosage pathogenicity</Haploinsufficiency>
          <Triplosensitivity last_evaluated="2021-01-12" ClinGen="https://www.ncbi.nlm.nih.gov/projects/dbvar/ISCA/isca_gene.cgi?sym=OCRL">No evidence available</Triplosensitivity>
        </Gene>
      </GeneList>
      <Name>NM_000276.4(OCRL):c.167_168del (p.Ile56fs)</Name>
      <CanonicalSPDI>NC_000023.11:129545004:TT:</CanonicalSPDI>
      <VariantType>Deletion</VariantType>
      <Location>
        <CytogeneticLocation>Xq26.1</CytogeneticLocation>
        <SequenceLocation Assembly="GRCh38" AssemblyAccessionVersion="GCF_000001405.38" forDisplay="true" AssemblyStatus="current" Chr="X" Accession="NC_000023.11" start="129545005" stop="129545006" display_start="129545005" display_stop="129545006" variantLength="2" positionVCF="129545004" referenceAlleleVCF="ATT" alternateAlleleVCF="A" />
        <SequenceLocation Assembly="GRCh37" AssemblyAccessionVersion="GCF_000001405.25" AssemblyStatus="previous" Chr="X" Accession="NC_000023.10" start="128678982" stop="128678983" display_start="128678982" display_stop="128678983" variantLength="2" positionVCF="128678981" referenceAlleleVCF="ATT" alternateAlleleVCF="A" />
      </Location>
      <ProteinChange>I56fs</ProteinChange>
      <ProteinChange>I57fs</ProteinChange>
      <HGVSlist>
        <HGVS Assembly="GRCh37" Type="genomic, top-level">
          <NucleotideExpression sequenceAccessionVersion="NC_000023.10" sequenceAccession="NC_000023" sequenceVersion="10" change="g.128678982_128678983del" Assembly="GRCh37">
            <Expression>NC_000023.10:g.128678982_128678983del</Expression>
          </NucleotideExpression>
        </HGVS>
        <HGVS Assembly="GRCh38" Type="genomic, top-level">
          <NucleotideExpression sequenceAccessionVersion="NC_000023.11" sequenceAccession="NC_000023" sequenceVersion="11" change="g.129545005_129545006del" Assembly="GRCh38">
            <Expression>NC_000023.11:g.129545005_129545006del</Expression>
          </NucleotideExpression>
        </HGVS>
        <HGVS Type="genomic">
          <NucleotideExpression sequenceAccessionVersion="NG_008638.1" sequenceAccession="NG_008638" sequenceVersion="1" change="g.9731_9732del">
            <Expression>NG_008638.1:g.9731_9732del</Expression>
          </NucleotideExpression>
        </HGVS>
        <HGVS Type="coding">
          <NucleotideExpression sequenceAccessionVersion="NM_000276.4" sequenceAccession="NM_000276" sequenceVersion="4" change="c.167_168del" MANESelect="true">
            <Expression>NM_000276.4:c.167_168del</Expression>
          </NucleotideExpression>
          <ProteinExpression sequenceAccessionVersion="NP_000267.2" sequenceAccession="NP_000267" sequenceVersion="2" change="p.Ile56fs">
            <Expression>NP_000267.2:p.Ile56fs</Expression>
          </ProteinExpression>
          <MolecularConsequence ID="SO:0001589" Type="frameshift variant" DB="SO" />
        </HGVS>
        <HGVS Type="coding">
          <NucleotideExpression sequenceAccessionVersion="NM_001318784.2" sequenceAccession="NM_001318784" sequenceVersion="2" change="c.170_171del">
            <Expression>NM_001318784.2:c.170_171del</Expression>
          </NucleotideExpression>
          <ProteinExpression sequenceAccessionVersion="NP_001305713.1" sequenceAccession="NP_001305713" sequenceVersion="1" change="p.Ile57fs">
            <Expression>NP_001305713.1:p.Ile57fs</Expression>
          </ProteinExpression>
          <MolecularConsequence ID="SO:0001589" Type="frameshift variant" DB="SO" />
        </HGVS>
        <HGVS Type="coding">
          <NucleotideExpression sequenceAccessionVersion="NM_001587.4" sequenceAccession="NM_001587" sequenceVersion="4" change="c.167_168del">
            <Expression>NM_001587.4:c.167_168del</Expression>
          </NucleotideExpression>
          <ProteinExpression sequenceAccessionVersion="NP_001578.2" sequenceAccession="NP_001578" sequenceVersion="2" change="p.Ile56fs">
            <Expression>NP_001578.2:p.Ile56fs</Expression>
          </ProteinExpression>
          <MolecularConsequence ID="SO:0001589" Type="frameshift variant" DB="SO" />
        </HGVS>
      </HGVSlist>
      <XRefList>
        <XRef Type="Allelic variant" ID="300535.0009" DB="OMIM" />
        <XRef Type="rs" ID="2124388022" DB="dbSNP" />
      </XRefList>
    </SimpleAllele>
    <RCVList>
      <RCVAccession Title="NM_000276.4(OCRL):c.167_168del (p.Ile56fs) AND Dent disease type 2" Accession="RCV000022865" Version="4">
        <ClassifiedConditionList TraitSetID="3032">
          <ClassifiedCondition DB="MedGen" ID="C1845167">Dent disease type 2</ClassifiedCondition>
        </ClassifiedConditionList>
        <RCVClassifications>
          <GermlineClassification>
            <ReviewStatus>no assertion criteria provided</ReviewStatus>
            <Description DateLastEvaluated="2021-06-22" SubmissionCount="1">Pathogenic</Description>
          </GermlineClassification>
        </RCVClassifications>
      </RCVAccession>
    </RCVList>
    <Classifications>
      <GermlineClassification DateLastEvaluated="2021-06-22" NumberOfSubmissions="1" NumberOfSubmitters="1" DateCreated="2021-06-26" MostRecentSubmission="2021-06-26">
        <ReviewStatus>no assertion criteria provided</ReviewStatus>
        <Description>Pathogenic</Description>
        <Citation Type="general">
          <ID Source="PubMed">27625797</ID>
        </Citation>
        <ConditionList>
          <TraitSet ID="3032" Type="Disease" ContributesToAggregateClassification="true">
            <Trait ID="1952" Type="Disease">
              <Name>
                <ElementValue Type="Preferred">Dent disease type 2</ElementValue>
                <XRef ID="MONDO:0010359" DB="MONDO" />
              </Name>
              <AttributeSet>
                <Attribute Type="public definition">Dent disease, an X-linked disorder of proximal renal tubular dysfunction, is characterized by low molecular weight (LMW) proteinuria, hypercalciuria, and at least one additional finding including nephrocalcinosis, nephrolithiasis, hematuria, hypophosphatemia, chronic kidney disease (CKD), and evidence of X-linked inheritance. Males younger than age ten years may manifest only LMW proteinuria and/or hypercalciuria, which are usually asymptomatic. Thirty to 80% of affected males develop end-stage renal disease (ESRD) between ages 30 and 50 years; in some instances ESRD does not develop until the sixth decade of life or later. The disease may also be accompanied by rickets or osteomalacia, growth restriction, and short stature. Disease severity can vary within the same family. Males with Dent disease 2 (caused by pathogenic variants in OCRL) may also have mild intellectual disability, cataracts, and/or elevated muscle enzymes. Due to random X-chromosome inactivation, some female carriers may manifest hypercalciuria and, rarely, renal calculi and moderate LMW proteinuria. Females rarely develop CKD.</Attribute>
                <XRef ID="NBK99494" DB="GeneReviews" />
              </AttributeSet>
              <AttributeSet>
                <Attribute Type="GARD id" integerValue="10645" />
                <XRef ID="10645" DB="Office of Rare Diseases" />
              </AttributeSet>
              <Citation Type="review" Abbrev="GeneReviews">
                <ID Source="PubMed">22876375</ID>
                <ID Source="BookShelf">NBK99494</ID>
              </Citation>
              <XRef ID="1652" DB="Orphanet" />
              <XRef ID="93623" DB="Orphanet" />
              <XRef ID="C1845167" DB="MedGen" />
              <XRef ID="MONDO:0010359" DB="MONDO" />
              <XRef Type="MIM" ID="300555" DB="OMIM" />
            </Trait>
          </TraitSet>
        </ConditionList>
      </GermlineClassification>
    </Classifications>
    <ClinicalAssertionList>
      <ClinicalAssertion ID="49412" SubmissionDate="2021-06-22" DateLastUpdated="2021-06-26" DateCreated="2013-04-04">
        <ClinVarSubmissionID localKey="300535.0009_DENT DISEASE 2" title="OCRL, 2-BP DEL, 166TT_DENT DISEASE 2" />
        <ClinVarAccession Accession="SCV000044156" DateUpdated="2021-06-26" DateCreated="2013-04-04" Type="SCV" Version="3" SubmitterName="OMIM" OrgID="3" OrganizationCategory="resource" />
        <RecordStatus>current</RecordStatus>
        <Classification DateLastEvaluated="2021-06-22">
          <ReviewStatus>no assertion criteria provided</ReviewStatus>
          <GermlineClassification>Pathogenic</GermlineClassification>
        </Classification>
        <Assertion>variation to disease</Assertion>
        <ObservedInList>
          <ObservedIn>
            <Sample>
              <Origin>germline</Origin>
              <Species>human</Species>
              <AffectedStatus>not provided</AffectedStatus>
            </Sample>
            <Method>
              <MethodType>literature only</MethodType>
            </Method>
            <ObservedData>
              <Attribute Type="Description">In a boy with Dent disease-2 (DENT2; 300555), Bockenhauer et al. (2012) identified a 2-bp deletion (166delTT) in exon 4 of the OCRL gene, resulting in a frameshift. The patient had low molecular weight proteinuria, hypercalciuria, and mild aminoaciduria, but no other extrarenal abnormalities. His unaffected mother carried the mutation.</Attribute>
              <Citation>
                <ID Source="PubMed">27625797</ID>
              </Citation>
              <XRef DB="OMIM" ID="300555" Type="MIM" />
            </ObservedData>
          </ObservedIn>
        </ObservedInList>
        <SimpleAllele>
          <GeneList>
            <Gene Symbol="OCRL" />
          </GeneList>
          <Name>OCRL, 2-BP DEL, 166TT</Name>
          <VariantType>Variation</VariantType>
          <OtherNameList>
            <Name Type="NonHGVS">2-BP DEL, 166TT</Name>
          </OtherNameList>
          <XRefList>
            <XRef DB="OMIM" ID="300535.0009" Type="Allelic variant" />
          </XRefList>
        </SimpleAllele>
        <TraitSet Type="Disease">
          <Trait Type="Disease">
            <Name>
              <ElementValue Type="Preferred">DENT DISEASE 2</ElementValue>
            </Name>
          </Trait>
        </TraitSet>
      </ClinicalAssertion>
    </ClinicalAssertionList>
    <TraitMappingList>
      <TraitMapping ClinicalAssertionID="49412" TraitType="Disease" MappingType="Name" MappingValue="DENT DISEASE 2" MappingRef="Preferred">
        <MedGen CUI="C1845167" Name="Dent disease type 2" />
      </TraitMapping>
    </TraitMappingList>
  </ClassifiedRecord>
</VariationArchive>

